Primary immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder, characterised by an isolated thrombocytopenia, in the absence of an obvious underlying cause or illness. Annemieke Laarhoven investigates whether direct treatment with a one-off dose of intravenous gammaglobulins in children newly diagnosed with ITP can prevent the disease from becoming chronic.
A.G. Laarhoven, Pediatric Immune Thrombocytopenia: Catching Platelets.
Prof. C.E. van der Schoot
Dr M. de Haas (Sanquin Research)
Dr G. Vidarsson
Dr M.C.A. Bruin (UMC Utrecht)
This event is open to the public.